EAT is up +49.38%% since April’24 pick View All Top Buy Picks
$4.15
+0 (+0%)
At Close: Aug 17, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile
Currently predicting for Thu, 27 Jun 2024

ZFGN Predictions History

5 years ago
 NameNotImportant predicted that ZFGN for 2019-05-06 is going $2.80 (7.28%)

5 years ago
 NameNotImportant predicted that ZFGN for 2019-04-30 is going $2.49 (-2.73%)

5 years ago
 NameNotImportant predicted that ZFGN for 2019-04-24 is going $2.37 (-3.27%)

Click to get the best stock tips daily for free!

About Zafgen

Zafgen Zafgen, Inc., a biopharmaceutical company, focuses on the development of therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate is the Beloranib, an injection, which is in Phase III clinical trials for the treatment of obesity and hyperphagia in patients with Prader-Willi syndrome; that has completed Phase II clinical trials to treat hypothalamic injury-associated obesity, including craniopharyn... ZFGN Profile

Golden Star

Ticker Date Change Price
EVBG Jun 21 0.0863% $34.76
DDOG Jun 21 1.33% $117.57
BRK-A Jun 20 0.575% $617,249.90
EPD Jun 18 2.90% $28.30
USFD Jun 18 4.33% $53.14
INTC Jun 18 0.359% $30.63
UFPT Jun 18 2.05% $253.79
^DJI Jun 18 0.714% 38,834.86 points
RGA Jun 17 1.53% $203.90
MA Jun 17 1.68% $448.11
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT